Introduction
Host tissue homeostasis is regulated by the levels of tissue collagenases such as matrix metalloproteinases (MMPs). During inflammatory conditions such as arthritis and periodontitis (Kinane, 2000 , Grayson, et al., 2003 , the levels of MMPs increase and if uncontrolled could disrupt the homeostasis associated with matrix remodeling (Parks, et al., 2004) . Toll like Receptors (TLRs) of the innate immune system recognize a broad category of microbial pathogen associated molecular patterns (Janeway, 1989 , Janeway, 1992 . For instance, TLR2 recognizes structures from gram positive bacteria such as peptidoglycan and lipoteichoic acid (Schwandner, et al., 1999) and TLR4 recognizes lipopolysaccharide (LPS) from gram negative bacteria (Beutler, et al., 2003) .
Inflammatory cytokines such as TNF-α (Zhou, et al., 2003) and IL-1β (Wu, et al., 2004) secreted through TLR signaling induce and activate latent forms of MMPs.
Moreover, the conversion of biologically active forms of inflammatory cytokines such as IL-1β can be induced through certain MMPs such as MMP2 and MMP9 (Lefebvre, et al., 1991) . An imbalance in the levels of MMPs and TIMPs are implicated in neoplasms (Bramhall, et al., 1997 , Brehmer, et al., 2003 , cancer metastasis (Ueda, et al., 1996 , Ogata, et al., 2001 , ulcerative conditions of gastric mucosa (Rautelin, et al., 2009 ) and corneal mucosa (Gabison, et al., 2005) , neural (Mun-Bryce, et al., 2004) and cardiovascular (Squire, et al., 2004) injury and inflammatory conditions such as arthritis (Kanyama, et al., 2000 , Tchetverikov, et al., 2004 and periodontitis (Kubota, et al., 2008) . Although increased levels of TIMPs are implicated during inflammatory conditions such as periodontitis, these levels are considered to be insufficient to inhibit activated MMPs (Garlet, et al., 2004) . Interestingly, periodontal pathogens have the ability to increase the tissue destruction by inactivating TIMPs (Grenier & Mayrand, 2001 ).
MMP activity is tightly regulated at RNA transcription, protein synthesis, extracellular localization and activation (Page-McCaw, et al., 2007) . Moreover, the expression of TIMPs and alpha 2-macroglobulin provide additional regulatory measures to establish tissue homeostasis. Inflammatory conditions if not regulated lead to host tissue damage. Induction of endotoxin tolerance is one of the adaptive measures to curtail excessive host inflammatory response during chronic inflammatory conditions such as periodontitis (Muthukuru, et al., 2005 , Muthukuru & Cutler, 2006 . During the induction of endotoxin tolerance, the inflammatory cytokines are downmodulated in an effort to attain host tissue homeostasis. However, little is known how negative regulation of inflammatory response mediated by endotoxin tolerance affects the balance of MMPs and TIMPs and thereof regulates host tissue homeostasis.
In this study, concentrations of LPS from Porphyromonas gingivalis (PgLPS) and
Escherichia coli (EcLPS) were optimized based on equivalent NFκB activation.
TLR2 and TLR4 functional blocking antibodies were titrated for optimal TLR blocking. Human monocyte derived macrophages (MФ) were either stimulated once (sensitized) or stimulated and further challenged (to induce tolerance) with 1000ng / ml of PgLPS or 100ng / ml of EcLPS. The data suggests that PgLPS and EcLPS significantly induced the secretion of TNF-α and IL-1β relative to unstimulated controls. Relative to TLR2, blocking TLR4 significantly downmodulated secretion of TNF-α and IL-1β when MФ were stimulated with either PgLPS or EcLPS. However, levels of MMP9 were not affected with either TLR2 or TLR4 blocking but interestingly, induction of endotoxin tolerance downregulated the secretion of enzymatically active MMP9. This could be attributed to elevated levels of TIMP1 that were significantly upregulated during endotoxin tolerance. Induction of endotoxin tolerance that negatively regulated MMP9 could minimize tissue destruction during chronic inflammatory conditions. 
Materials and methods

LPS isolation
LPS was isolated from either P. gingivalis strain 381 (PgLPS) or type ATCC strain E. coli 25922 (EcLPS) by hot phenol-water extraction followed by isopycnic density gradient centrifugation and was further purified of contaminating nucleic acids, proteins, and lipoproteins. In addition, some of the LPS preparations (purified identically) were a gift of T. E. Van Dyke, Boston University, Goldman School of Dental Medicine. The purity of LPS was confirmed by gel electrophoresis, which detected visible LPS ladder staining pattern with silver staining and no visible proteins analyzed by Coomassie blue staining (data not shown).
Human peripheral blood monocyte derived M cultures
Monocytes were isolated from mononuclear fractions of peripheral blood of healthy donors by means of adherence to polystyrene culture flasks as previously described (Muthukuru, et al., 2005 , Muthukuru & Cutler, 2008 . Briefly, whole peripheral blood was centrifuged on Ficoll, and the mononuclear cell fraction peletted and resuspended in RPMI 1640 (Invitrogen) with 10% heat-inactivated fetal calf serum (Sigma, St. Louis, MO). Mononuclear cells ( 2.7 x 10 8 ) were seeded on 150ml polystyrene culture flasks and incubated for 2h at 37°C in a 5% CO 2 incubator. After the non-adherent cells were washed off, the adherent monocytes were retrieved from the culture dishes by using 1x trypsin-EDTA solution. Monocytes were cultured in RPMI 1640 with 10% heat-inactivated fetal calf serum (FCS). The percentages of viable monocytes (typically >90% after LPS stimulation) were monitored by trypan blue exclusion. Human blood-derived monocytes were cultured in the presence of macrophage (M ) colony-stimulating factor (M-CSF) for 5 to 7 days as previously reported (Muthukuru & Cutler, 2008) .
Briefly, the differentiation of monocytes into M was confirmed by the uptake of 
In vitro LPS stimulation and challenge: induction of endotoxin tolerance
For the purpose of LPS dose responses, PgLPS or EcLPS were employed at the concentrations of 10, 100 and 1000 ng/ml. M were stimulated with these concentrations of LPS for 24 hours. The in vitro design for induction of endotoxin tolerance has previously been described in detail previously (Muthukuru, et al., 2005 , Muthukuru & Cutler, 2006 , Muthukuru & Cutler, 2008 . Briefly, human M were incubated for 24 h either with no LPS stimulus (control) or with initial sensitization with 1000 ng/ml of P. gingivalis or 100ng/ml of E. coli LPS for 24 h followed by a challenge with the same LPS at the same initial dosage for a further duration of 24 h. The cells were then pelleted and washed with cold phosphatebuffered saline three times to be employed for subsequent experiments as described below.
Quantification of NF-κB activity
NF-κB activity was analyzed by performing quantification of active p65 by employing DNA-binding ELISA based TransAM kits from Active Motif according to manufacturer's instructions. Nuclear extracts from M cell cultures were added and the activated p65 was allowed to bind to oligonucleotides at its consensus binding site and was quantified using the pre-diluted antibody and generating a standard curve from recombinant p65 protein. All analyses were performed in triplicate.
Luciferase assay
Human embryonic kidney (HEK) 293 cells with NF-κB reporter construct (ELAM-1 firefly luciferase), the β-actin-Renilla luciferase reporter construct and the modified pDisplay expression vector were kindly provided by Dr. Richard
Darveau (University of Washington, Seattle, WA). These cells were cloned with the expression constructs for human TLR4 (phuTLR4), mCD14 (phumCD14) and MD2 (cells designated as HEK-TLR4) or with human TLR1 (phuTLR1) and TLR2 (phuTLR2) (cells designated as HEK-TLR2) into the modified pDisplay expression vector. HEK 293 cells were transfected by calcium phosphate precipitation in a 96-well plate assay format as previously described (Hajjar, et al., 2002) . Cells were washed twice with medium 3 hours after transfection and stimulated for 24 hours with either 1µg/ml of PgLPS or EcLPS. Cells were cultured, transfected and stimulated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS), 10% human AB serum at 37°C. Cells were washed with phosphate-buffered saline and lysed with 50μl of passive lysis buffer (Promega, Madison, WI). Reporter gene expression in each lysate (10μl) was measured using the Dual Luciferase reporter assay system (Promega, Madison, WI). Data are expressed as fold increase in relative light units (representing the ratio of ELAM-luciferase to β-actin Renilla-luciferase expression) relative to that of unstimulated controls. All experiments were performed in triplicate.
Quantification of cytokines
Cell culture supernatants were collected after stimulation and challenge with PgLPS and EcLPS for 24 hours. Culture supernatants were analyzed for secretion of TNF-α and IL-1β by flow cytometry using cytometric bead array (CBA Kit, BD Biosciences). Concentrations of cytokines were calculated based on a standard curve for each cytokine. The CBA software calculated cytokine levels in pg/ml.
Real-time RT-PCR analysis
(i) RNA extraction and cDNA synthesis Unstimulated M or PgLPS / EcLPS sensitized or tolerized M from in vitro cultures were placed in RNAlater RNA stabilizing reagent (Qiagen) and frozen at -80°C for later use. Frozen cells were subject to lysis / homogenization and total RNA was extracted using Qiagen RNeasy mini kits as specified by the manufacturer. Avian reverse transcriptase (RT) first-strand kits (Sigma) were used to synthesize cDNA from total RNA. The concentration of total RNA was determined at OD 260 . The purity of total RNA was determined by analysis of the OD 260 /OD 280 ratio. Small discrepancies in the total RNA concentration were rectified by loading the same concentration of RNA for cDNA synthesis.
(ii) Primers for PCR Nucleotide sequences were determined from PubMed (National Center for Biomedical Information) and the primers were custom designed using primer3 software. Presented in Table 1 are the sequences of the primers and product sizes of RT-PCR.
(iii) Real-time RT-PCR quantification Real-time RT-PCR analysis was performed using the iCycler (Bio-Rad, Hercules, Calif.) with SYBR Green kits (Bio-Rad) and mRNA quantification was performed by standard curve method as previously described (Muthukuru, et al., 2005 , Muthukuru & Cutler, 2006 . For each transcript analyzed, a standard curve with predetermined concentrations and serial diluted respective PCR amplification products from 0.1 to 0.00001 ng was constructed. This approach allows the standards to be amplified in the same way as the template cDNA in the unknown samples since the product sequence and size are identical. Levels of ß-actin mRNA served as an internal control to normalize samples for variations in sample volume loading, presence of inhibitors, and nucleic acid recovery during extraction and cDNA synthesis procedures. All analyses were performed in triplicate.
Western blot analysis of MMP-9 secretion
The total protein concentration from the culture supernatant of the M cultures as described above was quantitated using protein assay kits (Bio-Rad). Culture 
Results
PgLPS is less potent relative to EcLPS in inducing NFkB
The lipid A structure of P gingivalis LPS purified through conventional methods is a weak inducer of host inflammatory response relative to the canonical E coli Lipid A (Dixon & Darveau, 2005) . Stimulation with LPS activates TLR signaling culminating in NF-κB activation (Mancuso, et al., 2005) . M were stimulated with PgLPS or EcLPS with concentrations of 10, 100 or 1000 ng/ml. A dose dependent increase in NF-κB activation with either LPS is noted in Fig. 1A .
However, NF-κB levels were unaltered (relative to unstimulated controls) when stimulated with 10ng/ml of PgLPS but 1000ng/ml of PgLPS and 100ng/ml of EcLPS induced equivalent NF-κB activation (Fig. 1A) . Titration of anti-TLR2 and
anti-TLR4 blocking antibodies demonstrated optimal blocking at antibody concentration of 20µg/ml (Fig. 1B) . In subsequent experiments shown in Fig relative to that of β-actin. The data suggests that relative to unstimulated controls, PgLPS upregulated NF-κB expression in both HEK-TLR2 (Fig. 1C) and HEK-TLR4 cells (Fig. 1D) . EcLPS induced NF-κB in HEK-TLR4 (Fig. 1D) but not HEK-TLR2 cells (Fig. 1C) .
TLR blocking inhibits inflammatory cytokines but not MMP9
TLR signaling results in secretion of inflammatory cytokines such as TNF-α and IL-1β (Ozinsky, et al., 2000) . Subsequently, these cytokines provide the signals for MMP secretion and also mediate their activation (Zhou, et al., 2003 , Wu, et al., 2004 . M were stimulated with 1000 ng/ml of PgLPS or 100 ng/ml of EcLPS.
Anti-TLR2 and anti-TLR4 functional blocking antibodies were employed at 20µg/ml. Secretion of TNF-α ( Fig. 2A, 2B ) and IL-1β (Fig. 2C, 2D ) were significantly induced by PgLPS ( Fig. 2A, 2C) or EcLPS (Fig. 2B, 2D ) relative to unstimulated controls. However, EcLPS (Fig. 2B, 2D ) was more potent in inducing TNF-α and IL-1β relative to PgLPS ( Fig. 2A, 2C ). Blocking with anti-TLR4 antibody ( Fig. 2A -2D ) significantly reduced the secretion of TNF-α ( Fig.   2A, 2B ) and IL-1β (Fig. 2C, 2D ) secretion when M were stimulated with either PgLPS ( Fig. 2A, 2C) or EcLPS (Fig. 2B, 2D ). Anti-TLR2 functional blocking was not potent in downregulating these cytokines (Fig 2A -2D ). M stimulated with either PgLPS (Fig. 2E) or EcLPS (Fig. 2F ) significantly upregulated the expression of MMP9. Moreover, PgLPS was potent relative to EcLPS in inducing MMP9. Interestingly, blocking with either anti-TLR2 or anti-TLR4 antibodies did not downregulate the induction of MMP9 transcripts (Fig. 2E, 2F ).
Induction of endotoxin tolerance downregulates the secretion of MMP9
Inflammatory cytokines secreted in response to TLR signaling induce the expression of MMPs and also activate the latent forms of MMPs , Zhou, et al., 2003 , Wu, et al., 2004 . Induction of endotoxin tolerance is implicated in reprogramming TLR signaling and downmodulating cytokine secretion (Muthukuru, et al., 2005 , Muthukuru & Cutler, 2008 . However, little is known how negative regulation of inflammatory response during endotoxin tolerance influences the expression of MMPs. M were sensitized or further challenged to induce tolerance with either PgLPS or EcLPS as described in materials and methods. Culture supernatants were analyzed for MMP9 levels through western blot analysis (Fig. 3A, 3B ) and MMP9 activity through gelatin zymography (Fig. 3C, 3D ). When M were sensitized with PgLPS or EcLPS the levels of MMP9 was upregulated relative to that of the unstimulated M .
However, MMP9 was highly induced with PgLPS relative to stimulation with EcLPS. Induction of endotoxin tolerance with either PgLPS or EcLPS resulted in downregulation of MMP9 secretion relative to either PgLPS or EcLPS sensitization. Secretion of MMP9 analyzed through western blot (Fig. 3A, 3B) correlated with the gelatinolytic activity as analyzed by zymography (Fig. 3C, 3D ).
Disproportionate upregulation of TIMP1 relative to MMP9 during induction of endotoxin tolerance
In order to determine the underlying mechanism of downregulation of MMP9 during endotoxin tolerance, we analyzed the expression of TIMP1, an inhibitor of MMP9 activity along with the expression of MMP9 through quantitative real time
RT-PCR as described in materials and methods. Stimulation with PgLPS or
EcLPS significantly increased the mRNA expression of MMP9 (Fig. 4A ) and TIMP1 ( Fig. 4B ) relative to the unstimulated controls. Contrary to downregulation of MMP9 protein secretion (Fig. 3) , the transcript levels were upregulated by ~ 3 times during the induction of endotoxin tolerance with either PgLPS or EcLPS (Fig. 4A) . Interestingly, induction of tolerance through PgLPS or EcLPS significantly upregulated TIMP1 by 93 and 15 times respectively relative to sensitization with either LPS (Fig. 4B ). This disproportionate upregulation of TIMP1 (Fig. 4B ) relative to MMP9 (Fig. 4A ) are presented as a ratio of PgLPS or EcLPS challenged (tolerance) to sensitized groups (Fig. 4C ).
Discussion
Our results indicate that unlike inflammatory cytokines such as IL-1β and TNF-α, MMP9 and TIMP1 transcripts are resistant to downregulation during endotoxin tolerance. However, a disproportionate upregulation of TIMP1 relative to MMP9 could downregulate MMP9 protein activity. MMPs belong to the superfamily of endopeptidases that comprise more than 25 distinct proteins (Brinckerhoff & Matrisian, 2002) . MMPs facilitate trafficking of antigen presenting cells (APC) that patrol, capture the invading pathogens and subsequently migrate towards the lymphoid organs for antigen presentation (Osman, et al., 2002) . Also, MMPs play a crucial role during physiological conditions such as uterine tissue resorption, ovulation (Weeks, et al., 1976) and during endochondral bone morphogenesis (Ortega, et al., 2003 , Ortega, et al., 2004 . The MMP activities during these physiological conditions are tightly regulated and are counteracted by TIMPs E. coli is a gut commensal whose LPS can provoke septic shock syndrome (Polide-Figueiredo, et al., 2008) . Chronic periodontitis is an inflammatory disease of the oral mucosa (Seymour, 1991) mediated by periodontal pathogens such as P.
gingivalis (Kroes, et al., 1999) that share the common property of being gram negative, i.e., producing LPS (Socransky, et al., 1998 , Ezzo & Cutler, 2003 , Cohen, et al., 2004 . During these inflammatory conditions, LPS triggers inflammatory cytokine secretion and MMPs are induced and become activated by these inflammatory cytokines (Liacini, et al., 2003 , Cox, et al., 2006 . The Lipid A component of LPS is the biologically active moiety that contributes to septic shock syndrome and inflammatory conditions such as periodontitis. The biphosphorylated, hexa-acylated lipid A structure from E. coli is the most potent in provoking the host inflammatory response (Dixon & Darveau, 2005 structures have variability and P. gingivalis Lipid A structure which is monophosphorylated and penta-acylated closely resembles that of Bacteroides (Kumada, et al., 1995 , Al-Qutub, et al., 2006 . These deviations from the canonical lipid A of E. coli are less potent and profoundly impact the host innate immune response (Dixon & Darveau, 2005) .
In this study, we show a dose dependent activation of NFκB in M when stimulated with either PgLPS or EcLPS (Fig. 1A) . However, PgLPS induced equivalent NFκB activation at 10 times higher concentration relative to stimulation with EcLPS. Based on this data, 1000 ng/ml of PgLPS and 100 ng/ml of Ec LPS were employed in subsequent studies. Anti-TLR2 and anti-TLR4 blocking antibodies were titrated (Fig. 1B) and 20 µg/ml of these antibodies optimally blocked NFκB activation. Although LPS is primarily recognized by TLR4, LPS structures from oral mucosal pathogens such as P. gingivalis (Ezzo & Cutler, 2003) are recognized by TLR4 (Darveau, et al., 2002 , Coats, et al., 2003 and also by TLR2 (Hirschfeld, et al., 2001 , Hajishengallis, et al., 2002 , Kido, et al., 2003 , Martin, et al., 2003 . To further determine how our LPS preparations interact with TLR2 and TLR4, we employed HEK cells expressing NF-κB and β-actin-Renilla that were transiently transfected with either TLR1 / TLR2 (HEK-TLR2) or with TLR4, CD14 and MD2 (HEK-TLR4). It should be noted that TLR1
or TLR6 function as co-receptors for TLR2 signaling and CD14, MD2 and TLR4 complex effectively recognizes LPS structures (Beutler, et al., 2003) . The data suggests that stimulating with PgLPS resulted in upregulation of NFκB in both HEK-TLR2 and HEK-TLR4 cells but EcLPS specifically targeted TLR4 but not TLR2 ( Fig. 1C and 1D ).
Recognition of microbial structures through TLRs leads to secretion of inflammatory cytokines (Ozinsky, et al., 2000 , Uwiera, et al., 2001 , Blander & Medzhitov, 2004 . Subsequently, the secretion of cytokines such as TNF-α and IL-1β lead to induction and activation of latent forms of MMPs. (Liacini, et al., 2003 , Cox, et al., 2006 . Anti-TLR2 and anti-TLR4 functional blocking antibodies were employed to determine how TLRs mediate the secretion of TNF-α, IL-1β
and MMP9 when stimulated with PgLPS and EcLPS stimulation. M stimulated with either PgLPS or EcLPS significantly induced the secretion of TNF-α, IL-1β
and MMP9 relative to unstimulated controls ( Fig. 2A -2D ). However, EcLPS was a potent inducer of TNF-α and IL-1β relative to PgLPS. Interestingly, PgLPS (Fig.   2E ) was a potent inducer of MMP9 relative to stimulation with EcLPS (Fig. 2F ).
Due to structural mono-phosphorylation of PgLPS (relative to bi-phosphorylated EcLPS), and that PgLPS targets TLR2, the commensal receptor, the inflammatory response induced by PgLPS is relatively weaker than that of the putative EcLPS. Although PgLPS can target TLR4, structural variations of the biologically active lipid A component of PgLPS can also antagonize TLR4 activity (Liu, et al., 2008) . These results support our previous findings that EcLPS is a potent inducer of inflammatory cytokines such as TNF-α and IL-1β (Muthukuru, et al., 2005) and on the contrary, PgLPS strongly upregulates MMP9 (Jotwani, et . Anti-TLR4 blocking antibody reduced the secretion TNF-α and IL-1β (Fig 2A   -2D ). Interestingly, either TLR2 or TLR4 blocking antibodies did not affect the levels of MMP9 (Fig. 2E, 2F ). This data suggests that MMP9 may not be exclusively controlled by TLR signaling but could be influenced by downstream events such as cytokines secretion in response to TLR activation.
Immunosurveillance and immunoregulation are important in mucosal linings such as oral mucosa due to enormous microbial complexity and diversity (Paster, et al., 2001) . Induction of immune tolerance toward commensals combined with responsiveness to pathogens is essential to sustaining immune homeostasis while preventing life threatening infections (Yilmaz, et al., 2002) . We have previously reported through in situ studies and with in vitro models (Muthukuru, et al., 2005) that APCs such as M, downregulate the expression of TLRs and inflammatory cytokines such as IL-1β, IL-6 and TNF-α when induced to a state of endotoxin tolerance. In the present study, we show that secretion of MMP9 is downmodulated by induction of endotoxin tolerance mediated by either PgLPS or EcLPS (Fig. 3, Fig. 4 ). Despite downregulation of TNF-α and IL-1β with TLR blocking, levels of MMP9 was not affected. This suggests that low levels of cytokines could be sufficient in the induction of MMP9.
MMP9 is one of the two gelatinase (92 kDa; gelatinase B) that has two conserved motifs, the prodomain and the catalytic domain .
Similar to other collagenases, the conserved cysteine residue in the prodomain binds to zinc in the catalytic domain. The cleavage of the prodomain is required for activation of MMP9. In the latent form, proMMP9 binds to TIMP1 and can be activated by serine proteinase . In an effort to determine how MMP9 secretion was downregulated during the induction of endotoxin tolerance (Fig. 3) , the expression of TIMP1 and MMP9 transcripts were analyzed through real time RT-PCR (Fig. 4) . The data suggests that sensitization and challenge with PgLPS or EcLPS and induction of endotoxin tolerance induced a 3-fold upregulation of MMP9 transcripts relative to sensitization (Fig. 4A) . However, the expression of TIMP1 was significantly upregulated by 93 and 15 times during the induction of endotoxin tolerance with PgLPS and EcLPS respectively. This data suggests that, upregulation of TIMP1 expression during endotoxin tolerance could counteract MMP9 activities.
Although the induction and activation of MMPs are well understood, the regulation of TIMPs is less explored. TGF-β has multiple functions in facilitating tissue homeostasis. TGF-β has been implicated in downmodulating MMPs and inducing TIMPs during invasive breast cancer (Gomes, et al.) . On the contrary, blocking TGF-β activity is implicated in upregulation of MMP3 in the gut mucosa (Di Sabatino, et al., 2008) . Src homology 2 (SH2) domain containing 5′-inositol phosphatase (SHIP) is one of inhibitory phosphatases (Harder, et al., 2004) that is upregulated during the induction of endotoxin tolerance and during inflammatory conditions such as chronic periodontitis (Muthukuru & Cutler, 2006) . The expression of SHIP can be induced through autocrine action of TGF-β (Sly, et al., 2004) . In this context, TGF-β could play a common role in the induction of tolerance and upregulation of TIMP1. Also, anti-inflammatory cytokines such as IL10 have been demonstrated to be relatively unaltered during the induction of endotoxin tolerance when compared to downregulation of proinflammatory cytokines (Muthukuru, et al., 2005) . Interestingly, IL10 has been shown to downmodulate MMP2 / 9 (John, et al., 2002) and also induce the expression of TIMP1 (Stearns, et al., 1997 , Stearns, et al., 1999 . IL10 being relatively resistant to downmodulation (relative to pro-inflammatory cytokines such as IL-1β) during endotoxin tolerance and also, IL10 being able to downregulate MMP9 but upregulate TIMP1 could provide mechanistic clues as to how MMP9 activity could be downmodulated during endotoxin tolerance. Apart from the data we have presented here, no other studies are currently available that have explored the regulation of MMP / TIMP activities during the induction of endotoxin tolerance.
Regulation of MMP9 is implicated as a potential therapeutic target during chronic obstructive pulmonary disease and mitral stenosis (Muroski, et al., 2008) . Also, TGF-β may inhibit the growth of melanomas by specifically decreasing plasmin activity of tumor cells and could play a protective role during the early stages of tumor progression (Ramont, et al., 2003) . Understanding the signaling networks of MMPs, TIMPs and TGF-β pathways and exploration of negative inducers of inflammation such as induction of endotoxin tolerance could further facilitate therapeutic interventions.
Regulation of inflammatory response is crucial for preventing excessive host tissue damage and for establishing tissue homeostasis. Endotoxin tolerance is one such mechanism which attempts to curtail inflammation during sustained microbial challenge. MMPs and their antagonists namely TIMPs play important roles in regulating tissue catalytic processes. This study for the first time explores how MMP9 / TIMP1 activities are regulated during the induction of endotoxin tolerance.
FIGURE LEGENDS Figure 1 PgLPS is less potent relative to EcLPS in inducing NF-κB
M were stimulated with PgLPS or EcLPS at concentrations of 10, 100 or 1000 ng/ml. Activation of NF-κB was determined by analyzing the nuclear p65 component of NF-κB (A). 1000 ng/ml of PgLPS and 100 ng/ml of EcLPS induced equivalent NF-κB activation. Anti-TLR2 and anti-TLR4 functional antibodies were titrated for optimal blocking by determining NF-κB activity. 20 µg/ml induced optimal downregulation of p65 component of NF-κB (B). PgLPS upregulated NF-κB in HEK cells transiently transfected with TLR1 and TLR2 (HEK-TLR2) and TLR4, CD14 and MD2 (HEK-TLR4) and EcLPS specifically targeted TLR4 but not TLR2 (C and D).
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